ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease

Neurobiology of Disease

Volumn 18, Issue 1, 2005, Pages 119-125

  Macé, Sandrine ^a   Cousin, Emmanuelle ^a   Ricard, Sylvain ^a   Génin, Emmanuelle ^b   Spanakis, Emmanuel ^a   Lafargue Soubigou, Carole ^a   Génin, Bérengère ^a   Fournel, Raphaël ^a   Roche, Sandrine ^a   Haussy, Gilles ^a   Massey, Florence ^a   Soubigou, Stéphane ^a   Bréfort, Georges ^a   Benoit, Patrick ^a   Brice, Alexis ^c   Campion, Dominique ^c   Hollis, Melvyn ^a   Pradier, Laurent ^a   Benavides, Jésus ^a   Deleuze, Jean François ^a  

^a SANOFI   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c INSERM   (France)

Author keywords

ABCA2; Alzheimer's disease; Association study; Cholesterol

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; PHOSPHOLIPID;

ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CASE-CONTROL STUDIES; CHOLESTEROL; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; VARIATION (GENETICS);

EID: 19944429282     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.09.011     Document Type: Article

References (34)

1. G.R. Abecasis, and W.O. Cookson GOLD-graphical overview of linkage disequilibrium Bioinformatics 16 2000 182 183
2. L. Bertram, and R.E. Tanzi Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet. 13 1 2004 R135 R141
3. I. Casserly, and E. Topol Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins Lancet 363 2004 1139 1146
4. Z.J. Chen, B. Vulevic, K.E. Ile, A. Soulika, W. Davis Jr., P.B. Reiner, B.P. Connop, P. Nathwani, J.Q. Trojanowski, and K.D. Tew Association of ABCA2 expression with determinants of Alzheimer's disease FASEB J. 18 10 2004 1129 1131
5. W. Davis Jr., Z.J. Chen, K.E. Ile, and K.D. Tew Reciprocal regulation of expression of the human adenosine 5′-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors Nucleic Acids Res. 31 2003 1097 1107
6. W. Davis Jr., J.T. Boyd, K.E. Ile, and K.D. Tew Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells Biochim. Biophys. Acta 1683 2004 89 100
7. B. Devlin, and N. Risch A comparison of linkage disequilibrium measures for fine-scale mapping Genomics 29 1995 311 322
8. J.M. Dietschy, and S.D. Turley Cholesterol metabolism in the brain Curr. Opin. Lipidol. 12 2001 105 112
9. J. Duan, M.S. Wainwright, J.M. Comeron, N. Saitou, A.R. Sanders, J. Gelernter, and P.V. Gejman Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor Hum. Mol. Genet. 12 2003 205 216
10. A.M. Dunning, F. Durocher, C.S. Healey, M.D. Teare, S.E. McBride, F. Carlomagno, C.F. Xu, E. Dawson, S. Rhodes, S. Ueda, E. Lai, R.N. Luben, E.J. Van Rensburg, A. Mannermaa, V. Kataja, G. Rennart, I. Dunham, I. Purvis, D. Easton, and B.A. Ponder The extent of linkage disequilibrium in four populations with distinct demographic histories Am. J. Hum. Genet. 6 2000 1544 1554
11. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, M. Hennerici, K. Beyreuther, and T. Hartmann Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 98 2001 5856 5861
12. J. Hardy Toward Alzheimer therapies based on genetic knowledge Annu. Rev. Med. 55 2004 15 25
13. T. Hartmann Cholesterol, Aβ and Alzheimer's disease Trends Neurosci. 24 Suppl. 11 2001 S45 S48
14. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
15. W.E. Kaminski, A. Piehler, K. Pullmann, M. Porsch-Ozcurumez, C. Duong, G.M. Bared, C. Buchler, and G. Schmitz Complete coding sequence, promoter region and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages Biochem. Biophys. Res. Commun. 281 2001 249 258
16. H. Katzov, K. Chalmers, J. Palmgren, N. Andreasen, B. Johansson, N.J. Cairns, M. Gatz, G.K. Wilcock, S. Love, N.L. Pedersen, A.J. Brookes, K. Blennow, P.G. Kehoe, and J.A. Prince Genetic variants of ABCA1 modify Alzheimer's disease risk and quantitative traits related to beta-amyloid metabolism Hum. Mutat. 23 2004 358 367
17. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study Br. Med. J. 322 2001 1447 1451
18. G. McKahnn, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
19. A. Papassotiropoulos, J.R. Streffer, M. Tsolaki, S. Schmid, D. Thal, F. Nicosia, V. Iakovidou, A. Maddalena, D. Lutjohann, E. Ghebremedhin, T. Hegi, T. Pasch, M. Traxler, A. Bruhl, L. Benussi, G. Binetti, H. Braak, R.M. Nitsch, and C. Hock Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer's disease associated with an intronic CYP46 polymorphism Arch. Neurol. 60 2003 29 35
20. L. Puglielli, G. Konopka, E. Pack-Chung, L.A. Ingano, O. Berezovska, B.T. Hyman, T.Y. Chang, R.E. Tanzi, and D.M. Kovacs Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide Nat. Cell Biol. 3 2001 905 912
21. L. Puglielli, R.E. Tanzi, and D.M. Kovacs Alzheimer's disease: the cholesterol connection Nat. Neurosci. 6 2003 345 351
22. L.M. Refolo, M.A. Pappolla, J. LaFrancois, B. Malester, S.D. Schmidt, T. Thomas-Bryant, G.S. Tint, R. Wang, M. Mercken, S.S. Petanceska, and K.E. Duff A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease Neurobiol. Dis. 5 2001 890 899
23. S. Rust, M. Rosier, H. Funke, J. Real, Z. Amoura, J.C. Piette, J.F. Deleuze, H.B. Brewer, N. Duverger, P. Denefle, and G. Assmann Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nat. Genet. 22 1999 352 355
24. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, and M.J. Alberts Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 8 1993 1467 1472
25. G. Schmitz, and W.E. Kaminski ABCA2: a candidate regulator of neural transmembrane lipid transport Cell. Mol. Life Sci. 59 2002 1285 1295
26. M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C.G. Dotti, and K. Simons Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons Proc. Natl. Acad. Sci. U. S. A. 95 1998 6460 6464
27. M. Simons, P. Keller, J. Dichgans, and J.B. Schulz Cholesterol and Alzheimer's disease: is there a link? Neurology 57 2001 1089 1093
28. J.D. Smith, W. Le Goff, M. Settle, G. Brubaker, C. Waelde, A. Horwitz, and M.N. Oda ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I J. Lipid Res. 45 2004 635 644
29. StataCorp. Stata Statistical Software: release 7.0 2001 Stata Corporation College Station, TX
30. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2001 181 184
31. D.A. Tregouet, S. Ricard, V. Nicaud, I. Arnould, S. Soubigou, M. Rosier, N. Duverger, O. Poirier, S. Mace, F. Kee, C. Morrison, P. Denefle, L. Tiret, A. Evans, J.F. Deleuze, and F. Cambien In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction Arterioscler. Thromb. Vasc. Biol. 24 2004 775 7781
32. B. Vulevic, Z. Chen, J.T. Boyd, W. Davis Jr., E.S. Walsh, M.G. Belinsky, and K.D. Tew Cloning and characterization of human adenosine 5′-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2) Cancer Res. 61 2001 3339 3347
33. M.A. Wollmer, J.R. Streffer, D. Lutjohann, M. Tsolaki, V. Iakovidou, T. Hegi, T. Pasch, H.H. Jung, K. Bergmann, R.M. Nitsch, C. Hock, and A. Papassotiropoulos ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease Neurobiol. Aging 24 3 2003 421 426
34. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch. Neurol. 57 2000 1439 1443